Thiochromene derivatives as HIF hydroxylase inhibitors
申请人:Ho Wen-Bin
公开号:US08927591B2
公开(公告)日:2015-01-06
The present invention relates to novel compounds, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS
申请人:Fibrogen, Inc.
公开号:EP2370422A1
公开(公告)日:2011-10-05
US8927591B2
申请人:——
公开号:US8927591B2
公开(公告)日:2015-01-06
US9149476B2
申请人:——
公开号:US9149476B2
公开(公告)日:2015-10-06
[EN] THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS<br/>[FR] DÉRIVÉS DE THIOCHROMÈNE UTILES EN TANT QU'INHIBITEURS DE L'HYDROXYLASE HIF
申请人:FIBROGEN INC
公开号:WO2010056767A1
公开(公告)日:2010-05-20
The present invention relates to novel compounds, methods, and compositions capable of decreasing HEF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).